Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Avoiding Pitfalls and Costly Mistakes in Early Stage R&D

Posted on January 17th, 2019 by in Pharma R&D

Pharma R&D costs continue to rise rapidly. A well-known Tufts study estimated the average pre-tax cost per new approved prescription drug (including failures and capital costs) was nearly $2.6 billion in 2013. However, the creation of novel approved drugs has not kept up with investment over the past two decades. (more…)

Small Biotechs Progressing Beyond Startup Status

Posted on November 29th, 2018 by in Pharma R&D

When is a startup no longer a startup? Small biotech companies armed with a talented crop of scientists have been springing up all across the pharma landscape for the last several years, establishing buzzing hubs of innovation. Not all of them find their research efforts successful, but many do and then go on to be acquired by larger pharmaceutical firms that have the resources to bring their ideas to fruition. (more…)

Leveraging Partnerships to Rescue and Develop Promising Technologies

Posted on November 14th, 2018 by in Pharma R&D

There are a number of players in the field of innovative therapeutics for cancer and inflammatory disease, but our company, 4P-Pharma, is taking a somewhat different approach than most of our competition. (more…)